Bridgefront Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-10,216
| Closed | -$709K | – | 774 |
|
2025
Q1 | $709K | Buy |
10,216
+6,253
| +158% | +$434K | 0.2% | 164 |
|
2024
Q4 | $341K | Buy |
+3,963
| New | +$341K | 0.11% | 323 |
|
2023
Q3 | – | Sell |
-4,154
| Closed | -$336K | – | 546 |
|
2023
Q2 | $336K | Buy |
+4,154
| New | +$336K | 0.18% | 217 |
|
2021
Q2 | – | Sell |
-24,400
| Closed | -$823K | – | 810 |
|
2021
Q1 | $823K | Buy |
24,400
+17,592
| +258% | +$593K | 0.26% | 92 |
|
2020
Q4 | $238K | Buy |
+6,808
| New | +$238K | 0.08% | 455 |
|